Targeted deep sequencing of HIV-1 using the IonTorrentPGM platform

Journal of Virological Methods

Volumn 205, Issue , 2014, Pages 7-16

  Kijak, Gustavo H ^a   Sanders Buell, Eric ^a   Harbolick, Elizabeth A ^a   Pham, Phuc ^a   Chenine, Agnes L ^a   Eller, Leigh Anne ^a   Rono, Kathleen ^b   Robb, Merlin L ^a   Michael, Nelson L ^c   Kim, Jerome H ^c   Tovanabutra, Sodsai ^a  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

HIV 1; IonTorrent; Molecular evolution; Next generation sequencing; Targeted deep sequencing

Indexed keywords

ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; LIMIT OF DETECTION; MEASUREMENT ERROR; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; TARGETED DEEP SEQUENCING; VIREMIA; VIRUS RECOMBINATION; AMINO ACID SEQUENCE; DNA SEQUENCE; FEMALE; GENE LIBRARY; GENETIC RECOMBINATION; GENETIC VARIATION; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MUTATION; NUCLEOTIDE SEQUENCE; PROCEDURES; SEQUENCE ALIGNMENT; VIROLOGY;

AMINO ACID SEQUENCE; BASE SEQUENCE; EVOLUTION, MOLECULAR; FEMALE; GENE LIBRARY; GENETIC VARIATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; MUTATION; RECOMBINATION, GENETIC; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; VIREMIA;

EID: 84901020709     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2014.04.017     Document Type: Article

References (50)

1. Archer J., Weber J., Henry K., Winner D., Gibson R., Lee L., Paxinos E., Arts E.J., Robertson D.L., Mimms L., Quinones-Mateu M.E. Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism. PLoS One 2012, 7:e49602.
2. Armenia D., Vandenbroucke I., Fabeni L., Van Marck H., Cento V., D'Arrigo R., Van Wesenbeeck L., Scopelliti F., Micheli V., Bruzzone B., Lo Caputo S., Aerssens J., Rizzardini G., Tozzi V., Narciso P., Antinori A., Stuyver L., Perno C.F., Ceccherini-Silberstein F. Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing. J. Infect. Dis. 2012, 205:557-567.
3. Brockman M.A., Schneidewind A., Lahaie M., Schmidt A., Miura T., Desouza I., Ryvkin F., Derdeyn C.A., Allen S., Hunter E., Mulenga J., Goepfert P.A., Walker B.D., Allen T.M. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J. Virol. 2007, 81:12608-12618.
4. Cai F., Chen H., Hicks C.B., Bartlett J.A., Zhu J., Gao F. Detection of minor drug-resistant populations by parallel allele-specific sequencing. Nat. Methods 2007, 4:123-125.
5. Chang E. Next-generation sequencing methods: impact of sequencing accuracy on SNP discovery. Single Nucleotide Polymorphisms 2009, Humana Press, New York, NY. A. Komar (Ed.).
6. Chang M.W., Oliveira G., Yuan J., Okulicz J.F., Levy S., Torbett B.E. Rapid deep sequencing of patient-derived HIV with ion semiconductor technology. J. Virol. Methods 2013, 189:232-234.
7. Clavel F., Hoggan M.D., Willey R.L., Strebel K., Martin M.A., Repaske R. Genetic recombination of human immunodeficiency virus. J. Virol. 1989, 63:1455-1459.
8. Coffin J., Swanstrom R. HIV pathogenesis: dynamics and genetics of viral populations and infected cells. Cold Spring Harbor Perspect. Med. 2013, 3:a012526.
9. Di Giallonardo F., Zagordi O., Duport Y., Leemann C., Joos B., Kunzli-Gontarczyk M., Bruggmann R., Beerenwinkel N., Gunthard H.F., Metzner K.J. Next-generation sequencing of HIV-1 RNA genomes: determination of error rates and minimizing artificial recombination. PLoS One 2013, 8:e74249.
10. Fischer W., Ganusov V.V., Giorgi E.E., Hraber P.T., Keele B.F., Leitner T., Han C.S., Gleasner C.D., Green L., Lo C.C., Nag A., Wallstrom T.C., Wang S., McMichael A.J., Haynes B.F., Hahn B.H., Perelson A.S., Borrow P., Shaw G.M., Bhattacharya T., Korber B.T. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One 2010, 5:e12303.
11. Gibson R.M., Meyer A.M., Winner D., Archer J., Feyertag F., Ruiz-Mateos E., Leal M., Robertson D.L., Schmotzer C.L., Quinones-Mateu M.E. Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism. Antimicrob. Agents Chemother. 2014, 58:2167-2185.
12. Gnanakaran S., Lang D., Daniels M., Bhattacharya T., Derdeyn C.A., Korber B. Clade-specific differences between human immunodeficiency virus type 1 clades B and C: diversity and correlations in C3-V4 regions of gp120. J. Virol. 2007, 81:4886-4891.
13. Goonetilleke N., Liu M.K., Salazar-Gonzalez J.F., Ferrari G., Giorgi E., Ganusov V.V., Keele B.F., Learn G.H., Turnbull E.L., Salazar M.G., Weinhold K.J., Moore S., Letvin N., Haynes B.F., Cohen M.S., Hraber P., Bhattacharya T., Borrow P., Perelson A.S., Hahn B.H., Shaw G.M., Korber B.T., McMichael A.J. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J. Exp. Med. 2009, 206:1253-1272.
14. Hedskog C., Mild M., Jernberg J., Sherwood E., Bratt G., Leitner T., Lundeberg J., Andersson B., Albert J. Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing. PLoS One 2010, 5:e11345.
15. Hedskog C., Brodin J., Heddini A., Bratt G., Albert J., Mild M. Longitudinal ultradeep characterization of HIV type 1 R5 and X4 subpopulations in patients followed from primary infection to coreceptor switch. AIDS Res. Hum. Retroviruses 2013, 29:1237-1244.
16. Keele B.F., Giorgi E.E., Salazar-Gonzalez J.F., Decker J.M., Pham K.T., Salazar M.G., Sun C., Grayson T., Wang S., Li H., Wei X., Jiang C., Kirchherr J.L., Gao F., Anderson J.A., Ping L.H., Swanstrom R., Tomaras G.D., Blattner W.A., Goepfert P.A., Kilby J.M., Saag M.S., Delwart E.L., Busch M.P., Cohen M.S., Montefiori D.C., Haynes B.F., Gaschen B., Athreya G.S., Lee H.Y., Wood N., Seoighe C., Perelson A.S., Bhattacharya T., Korber B.T., Hahn B.H., Shaw G.M. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Nat. Acad. Sci. U.S.A. 2008, 105:7552-7557.
17. Kijak G.H., Janini L.M., Tovanabutra S., Sanders-Buell E., Arroyo M.A., Robb M.L., Michael N.L., Birx D.L., McCutchan F.E. Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells. Virology 2008, 376:101-111.
18. Kijak G., Sanders-Buell W., Rolland M., Li H., Bates A., Bose M., O'Sullivan A., Eller L., O'Connell R., Shaw G., Michael N., Kim J., Robb M., Tovanabutra S. Incident cases characterization and deep sequencing provide new insight into multiplicity of infection and HIV evolution in very early acute infection. AIDS Vaccine 2012, Boston, MA 2012, http://www.vaccineenterprise.org/conference/2012/, abstract number: P05.06.
19. Kijak G.H., Pham P., Sanders-Buell E., Harbolick E.A., Eller L.A., Robb M.L., Michael N.L., Kim J.H., Tovanabutra S. Nautilus: a bioinformatics package for the analysis of HIV type 1 targeted deep sequencing data. AIDS Res. Hum. Retroviruses 2013, 29:1361-1364.
20. Korber B., Foley B., Kuiken C., Pillai S., Sodroski J. Numbering positions in HIV relative to HXB2CG. Human Retroviruses and AIDS 1998, III-102-III-111. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM. B. Korber, C. Kuiken, B. Foley, B. Hahn, F. McCutchan, J. Mellors, J. Sodroski (Eds.).
21. Larder B.A., Kemp S.D. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 1989, 246:1155-1158.
22. Larsen B.B., Chen L., Maust B.S., Kim M., Zhao H., Deng W., Westfall D., Beck I., Frenkel L.M., Mullins J.I. Improved detection of rare HIV-1 variants using 454 pyrosequencing. PLoS One 2013, 8:e76502.
23. Leslie A.J., Pfafferott K.J., Chetty P., Draenert R., Addo M.M., Feeney M., Tang Y., Holmes E.C., Allen T., Prado J.G., Altfeld M., Brander C., Dixon C., Ramduth D., Jeena P., Thomas S.A., St John A., Roach T.A., Kupfer B., Luzzi G., Edwards A., Taylor G., Lyall H., Tudor-Williams G., Novelli V., Martinez-Picado J., Kiepiela P., Walker B.D., Goulder P.J. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 2004, 10:282-289.
24. Li J.Z., Paredes R., Ribaudo H.J., Svarovskaia E.S., Metzner K.J., Kozal M.J., Hullsiek K.H., Balduin M., Jakobsen M.R., Geretti A.M., Thiebaut R., Ostergaard L., Masquelier B., Johnson J.A., Miller M.D., Kuritzkes D.R. Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis. J. Am. Med. Assoc. 2011, 305:1327-1335.
25. McCutchan F.E., Hoelscher M., Tovanabutra S., Piyasirisilp S., Sanders-Buell E., Ramos G., Jagodzinski L., Polonis V., Maboko L., Mmbando D., Hoffmann O., Riedner G., von Sonnenburg F., Robb M., Birx D.L. In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection. J. Virol. 2005, 79:11693-11704.
26. Messiaen P., Verhofstede C., Vandenbroucke I., Dinakis S., Van Eygen V., Thys K., Winters B., Aerssens J., Vogelaers D., Stuyver L.J., Vandekerckhove L. Ultra-deep sequencing of HIV-1 reverse transcriptase before start of an NNRTI-based regimen in treatment-naive patients. Virology 2012, 426:7-11.
27. Mild M., Hedskog C., Jernberg J., Albert J. Performance of ultra-deep pyrosequencing in analysis of HIV-1 pol gene variation. PLoS One 2011, 6:e22741.
28. Milne I., Stephen G., Bayer M., Cock P.J., Pritchard L., Cardle L., Shaw P.D., Marshall D. Using Tablet for visual exploration of second-generation sequencing data. Brief Bioinf. 2013, 14:193-202.
29. Moore P.L., Ranchobe N., Lambson B.E., Gray E.S., Cave E., Abrahams M.R., Bandawe G., Mlisana K., Abdool Karim S.S., Williamson C., Morris L. Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS Pathog. 2009, 5:e1000598.
30. Mukherjee R., Jensen S.T., Male F., Bittinger K., Hodinka R.L., Miller M.D., Bushman F.D. Switching between raltegravir resistance pathways analyzed by deep sequencing. AIDS 2011, 25:1951-1959.
31. Palmer S., Kearney M., Maldarelli F., Halvas E.K., Bixby C.J., Bazmi H., Rock D., Falloon J., Davey R.T., Dewar R.L., Metcalf J.A., Hammer S., Mellors J.W., Coffin J.M. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J. Clin. Microbiol. 2005, 43:406-413.
32. Pelak K., Shianna K.V., Ge D., Maia J.M., Zhu M., Smith J.P., Cirulli E.T., Fellay J., Dickson S.P., Gumbs C.E., Heinzen E.L., Need A.C., Ruzzo E.K., Singh A., Campbell C.R., Hong L.K., Lornsen K.A., McKenzie A.M., Sobreira N.L., Hoover-Fong J.E., Milner J.D., Ottman R., Haynes B.F., Goedert J.J., Goldstein D.B. The characterization of twenty sequenced human genomes. PLoS Genet. 2010, 6:e1001111.
33. Piyamongkol W., Bermudez M.G., Harper J.C., Wells D. Detailed investigation of factors influencing amplification efficiency and allele drop-out in single cell PCR: implications for preimplantation genetic diagnosis. Mol. Hum. Reprod. 2003, 9:411-420.
34. Poon A.F., Swenson L.C., Dong W.W., Deng W., Kosakovsky Pond S.L., Brumme Z.L., Mullins J.I., Richman D.D., Harrigan P.R., Frost S.D. Phylogenetic analysis of population-based and deep sequencing data to identify coevolving sites in the nef gene of HIV-1. Mol. Biol. Evol. 2010, 27:819-832.
35. Redd A.D., Collinson-Streng A., Martens C., Ricklefs S., Mullis C.E., Manucci J., Tobian A.A., Selig E.J., Laeyendecker O., Sewankambo N., Gray R.H., Serwadda D., Wawer M.J., Porcella S.F., Quinn T.C. Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencing. J. Clin. Microbiol. 2011, 49:2859-2867.
36. Redd A.D., Collinson-Streng A.N., Chatziandreou N., Mullis C.E., Laeyendecker O., Martens C., Ricklefs S., Kiwanuka N., Nyein P.H., Lutalo T., Grabowski M.K., Kong X., Manucci J., Sewankambo N., Wawer M.J., Gray R.H., Porcella S.F., Fauci A.S., Sagar M., Serwadda D., Quinn T.C. Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions. J. Infect. Dis. 2012, 206:1433-1442.
37. Richman D.D., Havlir D., Corbeil J., Looney D., Ignacio C., Spector S.A., Sullivan J., Cheeseman S., Barringer K., Pauletti D., et al. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy. J. Virol. 1994, 68:1660-1666.
38. Rothberg J.M., Hinz W., Rearick T.M., Schultz J., Mileski W., Davey M., Leamon J.H., Johnson K., Milgrew M.J., Edwards M., Hoon J., Simons J.F., Marran D., Myers J.W., Davidson J.F., Branting A., Nobile J.R., Puc B.P., Light D., Clark T.A., Huber M., Branciforte J.T., Stoner I.B., Cawley S.E., Lyons M., Fu Y., Homer N., Sedova M., Miao X., Reed B., Sabina J., Feierstein E., Schorn M., Alanjary M., Dimalanta E., Dressman D., Kasinskas R., Sokolsky T., Fidanza J.A., Namsaraev E., McKernan K.J., Williams A., Roth G.T., Bustillo J. An integrated semiconductor device enabling non-optical genome sequencing. Nature 2011, 475:348-352.
39. Rozera G., Abbate I., Bruselles A., Vlassi C., D'Offizi G., Narciso P., Chillemi G., Prosperi M., Ippolito G., Capobianchi M.R. Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations. Retrovirology 2009, 6:15.
40. Salazar-Gonzalez J.F., Salazar M.G., Keele B.F., Learn G.H., Giorgi E.E., Li H., Decker J.M., Wang S., Baalwa J., Kraus M.H., Parrish N.F., Shaw K.S., Guffey M.B., Bar K.J., Davis K.L., Ochsenbauer-Jambor C., Kappes J.C., Saag M.S., Cohen M.S., Mulenga J., Derdeyn C.A., Allen S., Hunter E., Markowitz M., Hraber P., Perelson A.S., Bhattacharya T., Haynes B.F., Korber B.T., Hahn B.H., Shaw G.M. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 2009, 206:1273-1289.
41. Shankarappa R., Margolick J.B., Gange S.J., Rodrigo A.G., Upchurch D., Farzadegan H., Gupta P., Rinaldo C.R., Learn G.H., He X., Huang X.L., Mullins J.I. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 1999, 73:10489-10502.
42. Shao W., Boltz V.F., Spindler J.E., Kearney M.F., Maldarelli F., Mellors J.W., Stewart C., Volfovsky N., Levitsky A., Stephens R.M., Coffin J.M. Analysis of 454 sequencing error rate, error sources, and artifact recombination for detection of Low-frequency drug resistance mutations in HIV-1 DNA. Retrovirology 2013, 10:18.
43. Simen B.B., Simons J.F., Hullsiek K.H., Novak R.M., Macarthur R.D., Baxter J.D., Huang C., Lubeski C., Turenchalk G.S., Braverman M.S., Desany B., Rothberg J.M., Egholm M., Kozal M.J. Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes. J. Infect. Dis. 2009, 199:693-701.
44. Swenson L.C., Moores A., Low A.J., Thielen A., Dong W., Woods C., Jensen M.A., Wynhoven B., Chan D., Glascock C., Harrigan P.R. Improved detection of CXCR4-using HIV by V3 genotyping: application of population-based and deep sequencing to plasma RNA and proviral DNA. J. Acquired Immune Defic. Syndr. 2010, 54:506-510.
45. Swenson L.C., Mo T., Dong W.W., Zhong X., Woods C.K., Jensen M.A., Thielen A., Chapman D., Lewis M., James I., Heera J., Valdez H., Harrigan P.R. Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients. J. Infect. Dis. 2011, 203:237-245.
46. Tsibris A.M., Korber B., Arnaout R., Russ C., Lo C.C., Leitner T., Gaschen B., Theiler J., Paredes R., Su Z., Hughes M.D., Gulick R.M., Greaves W., Coakley E., Flexner C., Nusbaum C., Kuritzkes D.R. Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo. PLoS One 2009, 4:e5683.
47. UNAIDS Global Report UNAIDS Report on the Global AIDS Epidemic 2013 2013, UNAIDS, Geneva, Switzerland.
48. Vandenbroucke I., Van Marck H., Mostmans W., Van Eygen V., Rondelez E., Thys K., Van Baelen K., Fransen K., Vaira D., Kabeya K., De Wit S., Florence E., Moutschen M., Vandekerckhove L., Verhofstede C., Stuyver L.J. HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays. AIDS Res. Ther. 2010, 7:4.
49. Wei X., Youngpairoj A.S., Garrido C., Zahonero N., Corral A., de Mendoza C., Heneine W., Johnson J.A., Garcia-Lerma J.G. Minority HIV mutation detection in dried blood spots indicates high specimen integrity and reveals hidden archived drug resistance. J. Clin. Virol. 2011, 50:148-152.
50. Zagordi O., Bhattacharya A., Eriksson N., Beerenwinkel N. ShoRAH: estimating the genetic diversity of a mixed sample from next-generation sequencing data. BMC Bioinf. 2011, 12:119.